NPS RADAR April 2007

Title Why read this
Alendronate (Alendro Once Weekly, Fosamax Once Weekly, Fosamax Plus) for osteoporosis in people at high risk of fracture Reviews extension of PBS listing for alendronate to include treatment of osteoporosis without fracture in older people with low bone mineral density scores.
Methylphenidate extended-release (Concerta) for attention deficit hyperactivity disorder (ADHD) Reviews use of extended-release methylphenidate, including comparison with immediate-release formulation and risk of cardiovascular adverse effects.
Brief item: Ciprofloxacin ear drops (Ciloxan) for chronic suppurative otitis media in Aboriginal and Torres Strait Islander people Ciprofloxacin ear drops (Ciloxan) were listed on the PBS to allow prescribing for chronic suppurative otitis media (CSOM) in Aboriginal and Torres Strait Islander people.
Brief item: Sildenafil (Revatio) listed for pulmonary hypertension Sildenafil (Revatio) was PBS listed as a Section 100 hospital Authority-required item for the treatment of primary pulmonary hypertension or pulmonary hypertension associated with connective tissue disease in patients categorised as WHO functional class III.
Brief item: Trandolapril 4 mg with verapamil sustained-release 240 mg fixed-dose combination tablet (Tarka) to be listed on PBS Trandolapril 4 mg with verapamil sustained release 240 mg fixed-dose combination tablet (Tarka) will be listed on the PBS for people already stabilised on antihypertensive treatment who wish to reduce the number of tablets they take each day.
Brief item: Medicine Update: the new consumer version of NPS RADAR Medicine Update, a new publication from NPS, will review newly listed PBS medicines for a consumer audience, with a quality use of medicines focus, and will be available on-line from the NPS website.
NPS RADAR April 2007 NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.